The ETFO ELHT Benefits Plan announced in May 2022 that plan members or their dependants using Humira, Enbrel, and Lantus would be required to switch to the corresponding biosimilar effective September 1, 2022, with a transition period to December 1, 2022.   If you still have not made this switch by November 30, 2022, coverage will no longer be available for these three medications effective December 1, 2022. 

Welcome to the thirteenth edition of Your Benefits! The Winter 2022/2023 includes the following articles:  Wellness is more than a hashtag;  Travelling over the holidays?  Providers say “use it or lose it” – we say use it well!

Effective September 1, 2022, plan members who are responsible for paying benefit premiums (**plan members with optional or supplemental life and/or part-time members with health and dental coverage) will now have premium deductions done by pre-authorized deductions (PAD) instead of via payroll deduction.  Those plan members** that have still not provided bank information to OTIP by November 30, 2022 will have applicable benefits terminated on December 1, 2022.